Clore Laboratory: News
Diabetes, Obesity and Metabolic Research

Home >> Clore Laboratory >> News >> News archive 2005

18 November 2005
Presentation by Mike Cawthorne on insights in diabetes drug discovery at the HSBC Diabetes Conference

1 November 2005
Mike Cawthorne lectures on fetal and early life programming at Garvan Institute and Deakin University

28 October 2005
Mike Cawthorne gives plenary lecture on anti-obesity research and drug targets at ASSO meeting

17 October 2005
Jon Arch presents studies of energy balance in DGAT-1 knockout mice to NAASO meeting

16 October 2005
Mike Cawthorne gives oral presentation on in utero programming by leptin treatment at NAASO meeting

13 September
Gene expression changes in pancreatic islets

12 September 2005
Jon Arch presents work on 11β-hydroxysteroid dehydrogenase inhibitor at EASD meeting

13 July 2005
Review published on fetal origins of insulin resistance and obesity

8 July 2005
Mohamed Zaibi joins Clore Laboratory as postdoctoral research fellow

7 July 2005
Abstracts on novel antidiabetic compounds presented at ADA meeting

6 June 2005
Mohamed Bellahcene joins Clore Laboratory as postdoctoral research fellow

4 June 2005
Jon Arch presents results demonstrating anti-obesity effect of CLA to ECO 2005 meeting

24 May 2005
Study of β-adrenoceptor agonist-mediated glucose uptake in muscle reported at BPS meeting on cell signalling

12 May 2005
Immunohistochemistry service launched for obesity, diabetes and skin research

10 May 2005
Clore Laboratory scientists available for face to face meetings at ECO 2005 and ADA San Diego

14 March 2005
Dipeptidyl peptidase (DPP-IV) inhibitor P32/98 improves glucose tolerance in diabetes model

10 March 2005
Mike Cawthorne gives invited lecture at ACS ProSpectives conference on drug discovery

2 March 2005
Claire Stocker gives invited lecture on developmental origins of obesity at Asia-Oceania conference

23 February 2005
Jon Arch gives invited lecture on stimulation of thermogenesis and energy metabolism

12 January 2005
Effects on insulin sensitivity of conjugated linoleic acid (CLA) after short term and long term treatment